Primary central nervous system lymphoma laboratory tests: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Neurosurgery]] | [[Category:Neurosurgery]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs content]] | [[Category:Needs content]] |
Revision as of 18:59, 27 August 2015
Primary central nervous system lymphoma Microchapters |
Differentiating Primary Central Nervous System Lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary central nervous system lymphoma laboratory tests On the Web |
American Roentgen Ray Society Images of Primary central nervous system lymphoma laboratory tests |
FDA on Primary central nervous system lymphoma laboratory tests |
CDC on Primary central nervous system lymphoma laboratory tests |
Primary central nervous system lymphoma laboratory tests in the news |
Blogs on Primary central nervous system lymphoma laboratory tests |
Directions to Hospitals Treating Primary central nervous system lymphoma |
Risk calculators and risk factors for Primary central nervous system lymphoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Laboratory Findings
- CD4+ count - Mean CD4+ count at time of diagnosis is ~50/uL.